)
Isaac Stoner
CEO
MindImmune
MindImmune CEO Isaac Stoner is a biotech entrepreneur with deep experience in drug discovery, immunology, and company building. He previously served as the founding CEO of Octagon Therapeutics, where he led efforts to develop first-in-class therapies targeting inflammatory and immune-mediated diseases. Isaac has spent his career translating scientific discoveries into novel therapeutic programs.
Before founding Octagon, Isaac held strategic and operational roles at FireFly BioWorks, Ion Torrent, PureTech Health, the the Martin Trust Center for MIT Entrepreneurship. In these positions, he helped launch and support multiple early-stage biotech companies. His work spans antibody and small-molecule drug discovery, translational immunology, and the integration of genomic and biomarker technologies and data. Mr Stoner is an EIR at the Slater Technology Fund and an advisor at KdT Ventures.
Isaac holds degrees from Brown University and MIT and continues to be widely involved in the broader Boston/Cambridge biotechnology ecosystem. He is motivated by the opportunity to build teams, advance transformative science, and develop medicines that meaningfully improve patients’ lives.
Sessions
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}